Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-05-06
2000-11-14
O'Sullivan, Peter
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514609, 546330, 546332, 564104, A61K 3144, A61K 3116
Patent
active
061470988
ABSTRACT:
Guanidine and diaminonitroethene derivatives represented by the formula ##STR1## wherein X, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are defined in the description, compositions thereof and methods for preparing the compounds are described. The se compounds are useful in the treatment of diseases of the central nervous system, cardiovascular system, pulmonary system, gastrointestinal system and endocrinologic system.
REFERENCES:
patent: 4567188 (1986-01-01), Niemers et al.
patent: 5087640 (1992-02-01), Morita et al.
Yoshizumi et al., Chem. Abst. 126:74528, 1996.
Myamoto et al., Chem Abst. 123:321699, 1995.
Yoshiizumi et al., Chem Pharm. Bull., vol. 44, No. 11, pp. 2042-2050 (1996).
Belezertseva et al. Chem Abst. 127:262499 (1997).
Abstract of Japanese patent application 06028936.
Abstract of Japanese patent application 3-244901 (Jan. 31, 1994).
Hansen John Bondo
Mogensen John Patrick
Tagmose Tina Moller
Novo Nordisk A S
O'Sullivan Peter
Rozek Carol E.
Zelson Steve T.
LandOfFree
Substituted guanidines and diaminonitroethenes, their preparatio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted guanidines and diaminonitroethenes, their preparatio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted guanidines and diaminonitroethenes, their preparatio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2065798